Upon completion of the transaction, AIX will hold approximately 72.0% of BGM’s equity interests and approximately 3.4% of its voting power while BGM will gain full control of RONS Technology and ...
BGM Group Ltd. (NASDAQ: BGM) ("the Company" or "BGM"), a leading global pharmaceutical enterprise, today announced its acquisition of the intelligent platform of AIX Inc. (NASDAQ: AIFU) ("AIX") valued ...
On the heels of a major fundraising effort this summer, Boulder-based Enveda Biosciences, which uses machine learning to discover naturally occurring drug compounds, recently closed on a $130 million ...